<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Lowe JR</submitter><funding>NIDA NIH HHS</funding><funding>NIAAA NIH HHS</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>With significant increases in opioid use/misuse and persistent high prevalence of prenatal alcohol exposure (PAE), identifying infants at risk for long-term developmental sequelae due to these exposures remains an urgent need. This study reports on developmental outcomes in young children from a prospective cohort, ENRICH-1, which recruited pregnant women and followed up maternal-infant pairs.&lt;h4>Methods&lt;/h4>Subjects were assigned to four study groups based on prenatal use of medications for opioid use disorder (MOUD), PAE, MOUD+PAE, and unexposed controls (UC). Mixed effects modeling was used to evaluate changes in the Bayley Scales of Infant Development-III (BSID-III) Cognitive, Language, and Motor scores between 6 and 20 months.&lt;h4>Results&lt;/h4>There was a significant </pubmed_abstract><journal>Pediatric research</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9911560</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Early developmental trajectory of children with prenatal alcohol and opioid exposure.</pubmed_title><pmcid>PMC9911560</pmcid><funding_grant_id>R01 AA021771</funding_grant_id><funding_grant_id>R34 DA050237</funding_grant_id><pubmed_authors>Roberts MH</pubmed_authors><pubmed_authors>Stephen JM</pubmed_authors><pubmed_authors>DiDomenico J</pubmed_authors><pubmed_authors>Rodriguez DE</pubmed_authors><pubmed_authors>Lowe JR</pubmed_authors><pubmed_authors>Bakhireva LN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Early developmental trajectory of children with prenatal alcohol and opioid exposure.</name><description>&lt;h4>Background&lt;/h4>With significant increases in opioid use/misuse and persistent high prevalence of prenatal alcohol exposure (PAE), identifying infants at risk for long-term developmental sequelae due to these exposures remains an urgent need. This study reports on developmental outcomes in young children from a prospective cohort, ENRICH-1, which recruited pregnant women and followed up maternal-infant pairs.&lt;h4>Methods&lt;/h4>Subjects were assigned to four study groups based on prenatal use of medications for opioid use disorder (MOUD), PAE, MOUD+PAE, and unexposed controls (UC). Mixed effects modeling was used to evaluate changes in the Bayley Scales of Infant Development-III (BSID-III) Cognitive, Language, and Motor scores between 6 and 20 months.&lt;h4>Results&lt;/h4>There was a significant </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-19T22:26:01.075Z</modification><creation>2025-04-19T22:26:01.075Z</creation></dates><accession>S-EPMC9911560</accession><cross_references><pubmed>35948606</pubmed><doi>10.1038/s41390-022-02252-z</doi></cross_references></HashMap>